Animal studies demonstrate that ipamorelin increases insulin secretion through both calcium channel and adrenergic receptor pathways
What GLP-1 Medications Actually Do GLP-1 (glucagon-like peptide-1) receptor agonists work by: Slowing gastric emptying Reducing appetite and food intake Improving glucose control Enhancing insulin response These effects are extremely effective for reducing caloric intake , which explains the dramatic short-term weight loss many patients see
In the SURPASS-2 study, tirzepatide 15 mg resulted in a faster and greater decline in body weight ( 5.5 kg) compared to semaglutide 1.0 mg, more than doubling the proportion of patients achieving at least 10% weight loss (57% vs 24%) [3]
Significant changes in diet or weightwhether intentional or unintentionalcan cause your period to stop, a condition known as amenorrhea
However, without controlled studies it remains unclear whether the degree of weight loss, the consistency of results, or the side effect profile matches what has been observed in clinical trials of FDA approved products